Hepatitis A vaccine

ALGAVAK® M

ALGAVAK® M is the only domestic vaccine against hepatitis A. The vaccine was developed in the science city of Koltsovo in 2003, and in 2006 received a production license. The drug is successfully used for the prevention of hepatitis A not only in Russia, but also in the CIS countries - Kazakhstan, Uzbekistan, Armenia, Belarus.

The ALGAVAC® M vaccine is produced in accordance with the international GMP standard.

In terms of quality and effectiveness, the Russian vaccine against hepatitis A is not inferior to the best foreign analogues, meets all the requirements of the WHO and the Ministry of Health of Russia. Unlike imported analogues, the composition of the "ALGAVAC® M" preparation contains no antibiotics and preservatives.

Points of sale and cost of the vaccine ALGAVAC® M

Vaccine cost:
adult dose (1 ml) - 960 rubles,
children's dose (0.5 ml) - 650 rubles.

Official distributors in Russia and the CIS:

OJSC "TD" Allergen "(Moscow)
+7 (495) 851-06-45
CJSC "MMK" Formed "(Moscow)
+7 (495) 741-79-09
LLC "MFC" Biorhythm "(Moscow)
+7 (495) 744-70-03
JSC "Medintorg" (Moscow)
+7 (495) 921-25-15
CJSC "Medservice-region" (Chelyabinsk)
+7 (351) 260-58-05
CJSC "Sandal LTD" (Yekaterinburg)
+7 (343) 331-90-53
CJSC "Sandal LTD" (Yekaterinburg)
+7 (343) 331-90-53